Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart Failure
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if exenatide will improve global cardiac function
in patients with type 2 diabetes mellitus and congestive heart failure, by favorable effects
on cardiac metabolism leading to improvement of cardiac efficiency.